摘要
目的:建立简便、快速的亲水作用色谱串联质谱法(HILIC-MS/MS)测定人血浆中的拉米夫定。方法:以13C1,15N2(拉米夫定为内标,血浆样品经乙腈沉淀蛋白后,采用Luna HILIC(100 mm×3.0 mm,3μm)柱分离。流动相为乙腈-5 mmol·L-1醋酸铵-甲酸(95∶5∶0.01,v/v/v),进样体积2μL,样品分析时间3 min。采用ESI源正离子模式、多反应监测(MRM),用于定量分析的离子反应分别为m/z230(112(拉米夫定)和m/z233(115(内标)。结果:测定人血浆中拉米夫定的线性范围为8.0~2000 ng·mL-1,定量下限为8.0 ng·mL-1,日内、日间精密度(RSD)均小于9.0%,准确度(RE)在-7.1%~2.7%之间。本法成功应用于健康受试者口服2种拉米夫定片后的生物等效性研究。结论:采用稳定同位素内标的HILIC-MS/MS法更为简便、快捷和准确,适用于人血浆样品中拉米夫定的测定。
Objective:To develop and validate a hydrophilic interaction chromatography-tandem mass spectrometric(HILIC-MS/MS) method for the determination of lamivudine in human plasma.Method:The plasma sample was protein precipitated with acetonitrile using the stable labelled 13C1,15N2-lamivudine as the internal standard.After sample preparation,the analyte and the IS were separated on a Luna HILIC(100 mm×3.0 mm,3 μm)column using 2 μL injection volume with a run time of 3.0 min.The mobile phase consisited of acetonitrile-5 mmol·L-1 ammonium acetate-formic acid(95∶ 5∶ 0.01,v/v/v).Detection was performed by tandem mass spectrometry using an electrosprasy source(ESI) in the positive ion mode,operating in the multiple reaction monitoring(MRM) of the transitions of m/z 230→112 and m/z 233→115 for lamivudine and the IS,respectively.Results:The linear calibration curves were obtained in the concentration range of 8.0-2000 ng·mL-1.The lower limit of quantification was 8.0 ng·mL-1.The intra-day and inter-day relative standard deviation over the entire concentration range was less than 9.0%.The accuracy was in the range of-7.1% to 2.7% in terms of relative error.The method was applied to evaluate the bioequivalence of two lamivudine tablet formulations in healthy volunteers.Conclusion:This method is simple,selective,rapid and suitable for the determination of lamivudine in human plasma.
出处
《药物分析杂志》
CAS
CSCD
北大核心
2011年第8期1448-1452,共5页
Chinese Journal of Pharmaceutical Analysis
关键词
核苷类
抗病毒
拉米夫定
液相色谱
质谱
血浆药物浓度
nucleoside antiviral
lamivudine
HPLC
mass spectrometry(MS)
plasma concentration